1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Post-COVID Conditions: new trials by email Literature Review of Post-COVID Conditions trials Research Report on Post-COVID Conditions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19 Fluvoxamine, Placebo - Post-COVID, POST-Covid 19 | Phase 3 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 160 | 2026-06-04 | 2026-06-09 |
Fatigue (1) · Post-Acute COVID-19 Syndrome (1)
COVID-19 (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1) · Post-Infectious Disorders (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1)
Fluvoxamine (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
Netherlands (1)